Four artemisinin-based treatments in african pregnant women with malaria

New England Journal of Medicine

Volumn 374, Issue 10, 2016, Pages 913-927

  Pekyi, Divine ^a   Ampromfi, Akua A ^a   Tinto, Halidou ^d   Traoré Coulibaly, Maminata ^d   Tahita, Marc C ^d   Valéa, Innocent ^d   Mwapasa, Victor ^e   Kalilani Phiri, Linda ^e   Kalanda, Gertrude ^e   Madanitsa, Mwayiwawo ^e   Ravinetto, Raffaella ^f,g   Mutabingwa, Theonest ⁱ   Gbekor, Prosper ^c   Tagbor, Harry ^b   Antwi, Gifty ^b   Menten, Joris ^g   De Crop, Maaike ^g   Claeys, Yves ^g   Schurmans, Celine ^g   Van Overmeir, Chantal ^g   Thriemer, Kamala ^g,j   Van Geertruyden, Jean Pierre ^h   D’alessandro, Umberto ^g,k,l   Nambozi, Michael ^m   Mulenga, Modest ^m   Hachizovu, Sebastian ^m   Kabuya, Jean Bertin B ^m   Mulenga, Joyce ^m   more..

^a Centre for Global Health Research   (Ghana)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c Juaben Government Hospital   (Ghana)

^d Nanoro   (Burkina Faso)

^e UNIVERSITY OF MALAWI   (Malawi)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ HUBERT KAIRUKI MEMORIAL UNIVERSITY   (Tanzania)

^j MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^k Medical Research Council Unit   (Gambia)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m Tropical Diseases Research Centre Ndola   (Zambia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE PLUS MEFLOQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AFRICA SOUTH OF THE SAHARA; ANEMIA; ARTICLE; ASTHENIA; BEHAVIOR CHANGE; BEHAVIOR DISORDER; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DECREASED APPETITE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS OUTCOME; HEADACHE; HUMAN; HYPOTENSION; INSOMNIA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALAISE; MALARIA FALCIPARUM; MULTICENTER STUDY; MUSCULOSKELETAL PAIN; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PARASITE CLEARANCE; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; UPPER ABDOMINAL PAIN; VOMITING; WEAKNESS; YOUNG ADULT; AFRICA; CLINICAL TRIAL; DRUG COMBINATION; GENETICS; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

ADULT; AFRICA; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; QUINOLINES; YOUNG ADULT;

EID: 84960412079     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1508606     Document Type: Article

References (29)

1. Takem EN, DAlessandro U. Malaria in pregnancy. Mediterr J Hematol Infect Dis 2013; 5(1): e2013010.
2. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet 2013; 383: 723-35.
3. DAlessandro U. Existing antimalarial agents and malaria-Treatment strategies. Expert Opin Pharmacother 2009; 10: 1291-306.
4. Lutje V, Gerritsen A, Siegfried N. Randomized controlled trials of malaria intervention trials in Africa, 1948 to 2007: A descriptive analysis. Malar J 2011; 10: 61.
5. Orton LC, Omari AAA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008; 4: CD004912.
6. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization, 2015 (http://apps .who .int/iris/bitstream/10665/162441/1/9789241549127-eng.pdf).
7. Nambozi M, Mulenga M, Halidou T, et al. Safe and efficacious artemisininbased combination treatments for African pregnant women with malaria: A multicentre randomized control trial. Reprod Health 2015; 12: 5.
8. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119: 417-23.
9. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization, 2008.
10. WorldWide Antimalarial Resistance Network (WWARN). Clinical module: data management and statistical analysis plan. 2012 (http://www.wwarn .org/sites/default/files/ClinicalDMSAP.pdf).
11. Dmitrienko A, DAgostino RB Sr. Traditional multiplicity adjustment methods in clinical trials. Stat Med 2013; 32: 5172-218.
12. Piola P, Nabasumba C, Turyakira E, et al. Efficacy and safety of artemetherlumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: An open-label, randomised, non-inferiority trial. Lancet Infect Dis 2010; 10: 762-9.
13. McGready R, White NJ, Nosten F. Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: A systematic review. BJOG 2011; 118: 123-35.
14. McGready R, Tan SO, Ashley EA, et al. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Med 2008; 5(12): e253.
15. Manyando C, Kayentao K, DAlessandro U, Okafor HU, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J 2012; 11: 141.
16. Kloprogge F, Piola P, Dhorda M, et al. Population pharmacokinetics of lumefantrine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda. CPT Pharmacometrics Syst Pharmacol 2013; 2: e83.
17. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 2010; 10: 405-16.
18. Valea I, Tinto H, Traore-Coulibaly M, et al. Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso. J Antimicrob Chemother 2014; 69: 2499-507.
19. Rijken MJ, McGready R, Jullien V, et al. Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. Antimicrob Agents Chemother 2011; 55: 4338-42.
20. Hoglund RM, Adam I, Hanpithakpong W, et al. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncompli-cated Plasmodium falciparum malaria in Sudan. Malar J 2012; 11: 398.
21. Four Artemisinin-Based Combinations (4ABC) Study Group. A head-To-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: A randomized trial. PLoS Med 2011; 8(11): e1001119.
22. Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal PJ, Dorsey G. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Antimicrob Agents Chemother 2007; 51: 3096-103.
23. Gupta V, Dorsey G, Hubbard AE, Rosenthal PJ, Greenhouse B. Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda. Malar J 2010; 9: 19.
24. Adam I, Tarning J, Lindegardh N, Mahgoub H, McGready R, Nosten F. Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2012; 87: 35-40.
25. Tagbor H, Bruce J, Browne E, Randal A, Greenwood B, Chandramohan D. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: A randomised trial. Lancet 2006; 368: 1349-56.
26. Clerk CA, Bruce J, Affipunguh PK, et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis 2008; 198: 1202-11.
27. Gonzez R, Mombo-Ngoma G, Ouraogo S, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: A multicentre randomized controlled trial. PLoS Med 2014; 11(9): e1001733.
28. Gonzez R Hellgren U Greenwood B Mendez C Mefloquine safety and tolerability in pregnancy: A systematic literature review Malar J 2014 13 75.
29. van Riemsdijk MM, Sturkenboom MC, Ditters JM, et al. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. Br J Clin Pharmacol 2004; 57: 506-12.